Cargando…

The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus

INTRODUCTION: The COVID-19 pandemic has brought major changes not only at the economic and social level but especially in the medical system. OBJECTIVE: To evaluate the impact of COVID-19 lockdown on the quality of glycemic control in Romanian patients with type 1 diabetes mellitus (T1DM). MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Gherbon, Adriana, Frandes, Mirela, Timar, Romulus, Timar, Bogdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637369/
https://www.ncbi.nlm.nih.gov/pubmed/36349052
http://dx.doi.org/10.2147/DMSO.S386614
_version_ 1784825172444839936
author Gherbon, Adriana
Frandes, Mirela
Timar, Romulus
Timar, Bogdan
author_facet Gherbon, Adriana
Frandes, Mirela
Timar, Romulus
Timar, Bogdan
author_sort Gherbon, Adriana
collection PubMed
description INTRODUCTION: The COVID-19 pandemic has brought major changes not only at the economic and social level but especially in the medical system. OBJECTIVE: To evaluate the impact of COVID-19 lockdown on the quality of glycemic control in Romanian patients with type 1 diabetes mellitus (T1DM). MATERIAL AND METHOD: Our study group included 102 Romanian volunteers’ patients with T1DM from both urban and rural areas. Data were collected during an interview, based on a structured questionnaire with multiple-choice questions about diabetes management during lockdown, how they interact with their diabetologist, how they accessed the treatment and what other factors influenced their diabetes management during the lockdown. RESULTS: Blood glucose levels were significantly higher in the MDII group as a consequence of delayed administration of insulin corrections due to inadequate insulin dosing (60% vs 31.81%; χ(2) = 5.51, p = 0.018). In addition, insulin pump users had improved response to stress and anxiety (ie, additional therapeutic safety being provided by use of insulin pump; in some devices, blood glucose being continuously monitored, leading to premature detection of important blood glucose excursions) compared to insulin pen users (χ(2) = 5.09, p = 0.024). In the context of hypoglycemia, we observed that in the pen MDII group, more users have administered an excess of insulin, compared with the pump users (80% vs 45.45%; χ(2) = 10.34; p = 0.001). CONCLUSION: A lower impact of COVID-19 lockdown on glycemic control was observed in patients with T1DM treated using insulin pumps compared to patients with T1DM who administered their insulin using insulin pens. Telemedicine and online consultations have brought significant improvements in diseases management. Stress, emotions, and anxiety were among the main reasons that led to increases in blood sugar levels, suggesting that the psychological impact may have long-term complications.
format Online
Article
Text
id pubmed-9637369
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-96373692022-11-07 The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus Gherbon, Adriana Frandes, Mirela Timar, Romulus Timar, Bogdan Diabetes Metab Syndr Obes Original Research INTRODUCTION: The COVID-19 pandemic has brought major changes not only at the economic and social level but especially in the medical system. OBJECTIVE: To evaluate the impact of COVID-19 lockdown on the quality of glycemic control in Romanian patients with type 1 diabetes mellitus (T1DM). MATERIAL AND METHOD: Our study group included 102 Romanian volunteers’ patients with T1DM from both urban and rural areas. Data were collected during an interview, based on a structured questionnaire with multiple-choice questions about diabetes management during lockdown, how they interact with their diabetologist, how they accessed the treatment and what other factors influenced their diabetes management during the lockdown. RESULTS: Blood glucose levels were significantly higher in the MDII group as a consequence of delayed administration of insulin corrections due to inadequate insulin dosing (60% vs 31.81%; χ(2) = 5.51, p = 0.018). In addition, insulin pump users had improved response to stress and anxiety (ie, additional therapeutic safety being provided by use of insulin pump; in some devices, blood glucose being continuously monitored, leading to premature detection of important blood glucose excursions) compared to insulin pen users (χ(2) = 5.09, p = 0.024). In the context of hypoglycemia, we observed that in the pen MDII group, more users have administered an excess of insulin, compared with the pump users (80% vs 45.45%; χ(2) = 10.34; p = 0.001). CONCLUSION: A lower impact of COVID-19 lockdown on glycemic control was observed in patients with T1DM treated using insulin pumps compared to patients with T1DM who administered their insulin using insulin pens. Telemedicine and online consultations have brought significant improvements in diseases management. Stress, emotions, and anxiety were among the main reasons that led to increases in blood sugar levels, suggesting that the psychological impact may have long-term complications. Dove 2022-11-02 /pmc/articles/PMC9637369/ /pubmed/36349052 http://dx.doi.org/10.2147/DMSO.S386614 Text en © 2022 Gherbon et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Gherbon, Adriana
Frandes, Mirela
Timar, Romulus
Timar, Bogdan
The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus
title The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus
title_full The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus
title_fullStr The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus
title_full_unstemmed The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus
title_short The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus
title_sort impact of covid-19 lockdown on glycemic balance in romanian patients with type 1 diabetes mellitus
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637369/
https://www.ncbi.nlm.nih.gov/pubmed/36349052
http://dx.doi.org/10.2147/DMSO.S386614
work_keys_str_mv AT gherbonadriana theimpactofcovid19lockdownonglycemicbalanceinromanianpatientswithtype1diabetesmellitus
AT frandesmirela theimpactofcovid19lockdownonglycemicbalanceinromanianpatientswithtype1diabetesmellitus
AT timarromulus theimpactofcovid19lockdownonglycemicbalanceinromanianpatientswithtype1diabetesmellitus
AT timarbogdan theimpactofcovid19lockdownonglycemicbalanceinromanianpatientswithtype1diabetesmellitus
AT gherbonadriana impactofcovid19lockdownonglycemicbalanceinromanianpatientswithtype1diabetesmellitus
AT frandesmirela impactofcovid19lockdownonglycemicbalanceinromanianpatientswithtype1diabetesmellitus
AT timarromulus impactofcovid19lockdownonglycemicbalanceinromanianpatientswithtype1diabetesmellitus
AT timarbogdan impactofcovid19lockdownonglycemicbalanceinromanianpatientswithtype1diabetesmellitus